Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Chinese Patent Office
UBS
QuintilesIMS
Queensland Health

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 9,399,627

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,399,627
Title:Substituted macrocyclic compounds having proteasome inhibitory activity
Abstract: The disclosure provides for novel compounds which have proteasome inhibitory activity, pharmaceutical compositions made thereof, and methods of use thereof to treat various disorders, including cancer and nonmalignant tumors.
Inventor(s): Pirrung; Michael C. (Riverside, CA)
Assignee: The Regents of the University of California (Oakland, CA)
Application Number:14/408,140
Patent Claims:see list of patent claims

Details for Patent 9,399,627

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial The Regents of the University of California (Oakland, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,399,627

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2013188750 Dec 19, 2013
World Intellectual Property Organization (WIPO) 2013188750 Feb 13, 2014
United States of America 2015141392 May 21, 2015
European Patent Office 2861565 Apr 22, 2015
European Patent Office 2861565 Dec 21, 2016
European Patent Office 2861565 Nov 11, 2015
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Cantor Fitzgerald
US Department of Justice
Queensland Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.